Life Insurance
Consensus Index

AI Consensus Fit Review

Corebridge Financial Final Expense Insurance Fit Review for People in Their 60s

Corebridge Financial is a good, but not clearly lowest-cost, fit for a nonsmoking buyer aged 60–69 seeking about $20,000 of permanent final expense coverage.

Research: 2026-09-217 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Corebridge Financial is a good, but not clearly lowest-cost, fit for a nonsmoking buyer aged 60–69 seeking about $20,000 of permanent final expense coverage. Two of seven platforms named Corebridge during the ranking stage, and six of seven returned a usable fit assessment. The strongest reason to consider it is SimpliNow Legacy Level Benefit: simplified-issue whole life with instant underwriting, no medical exam, and a full death benefit from day one when the applicant qualifies. The main limitation is that no public source verified an actual premium for this buyer profile, and the A.M. Best rating for the issuing insurer was under review with developing implications in 2026.

Research Snapshot

FieldFinding
Platform mentions in ranking stage2 of 7 platforms (anthropic, kimi)
Share of included platform responses28.6%
Average listed rank5.5
Best listed rank2
Relevant product/model/planSimpliNow Legacy (Level Benefit); Guaranteed Issue Whole Life as fallback
Overall use-case fitGood, with pricing unverified
Research date2026-09-21

Why Corebridge Financial Qualified for This Study

Questions This Section Answers

  • Why did Corebridge Financial qualify for this final expense insurance study for people in their 60s?
  • How many AI platforms named Corebridge Financial when ranking carriers for $20,000 of final expense coverage in the 60s?

Corebridge qualified because it offers permanent whole life products sized for this use case, not because it dominated the ranking stage. Two of seven platforms named the entity during ranking discovery, producing a 28.6% platform share, an average listed rank of 5.5, and a best listed rank of 2 [1]. Six of seven included platforms returned a usable fit assessment, so the fit findings rest on a broader base than the ranking mentions alone.

The qualification threshold was two mentions, and Corebridge cleared it narrowly. That matters for interpretation: this is a carrier that some platforms surfaced and others did not, which is different from a carrier every platform named. The platforms that did assess it converged on the same two products — SimpliNow Legacy and Guaranteed Issue Whole Life — which is the strongest signal in the dataset [3].

Corebridge is the marketing brand; American General life insurance Company is generally the issuing insurer, and the exact issuer must be confirmed for the applicant's state [7]. This distinction is not cosmetic — financial-strength ratings attach to the issuing company, not the brand.

The Product, Model, Plan, or Service Most Relevant to Final Expense Insurance for People in Their 60s

Questions This Section Answers

  • Which Corebridge Financial plan is best for a 60-year-old nonsmoker who wants $20,000 of permanent final expense coverage with no medical exam?
  • Is Corebridge Financial's SimpliNow Legacy Level Benefit better than its Guaranteed Issue Whole Life for a buyer in their 60s with average-to-good health?

SimpliNow Legacy Level Benefit is the relevant first choice for this buyer; Guaranteed Issue Whole Life is a fallback, not a default. SimpliNow Legacy is simplified-issue whole life built for final-expense needs, with Level and graded death-benefit designs [9]. The Level Benefit pays the full policy amount in all years when issued on that basis [11].

Coverage ranges differ by source. SimpliNow Legacy is described at $5,000–$35,000 [13], while one public agent source shows a $25,000 maximum for a SimpliNow Legacy Max variant [16]. Either way, a $20,000 target sits inside the stated range, subject to state, age, underwriting result, and product version.

Guaranteed Issue Whole Life is the no-health-question path: guaranteed acceptance for ages 50–80 with $5,000–$25,000 of coverage [17]. It carries a graded first-two-year structure, so it is generally the weaker choice for a reasonably healthy applicant who can qualify for Level Benefit.

Underwriting is the core selling point. Corebridge describes instant underwriting decisions, no medical exam, and no tele-interview for the simplified-issue process [9], with decisions possible in minutes and applications completable in as little as 20 minutes [20].

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Corebridge Financial final expense coverage for people in their 60s?
  • Does Corebridge Financial's final expense coverage stay in force for life if premiums are paid?

Platforms agreed on product structure, permanence, and the graded-versus-level distinction. Agreement here is strong but not unanimous — six of seven platforms returned a usable fit assessment, and one platform (deepseek) found no usable product detail at all.

The clearest shared finding is that these are whole life products designed to remain in force for life if required premiums are paid and the policy does not lapse [22]. Premiums are described as guaranteed not to increase [25].

Platforms also agreed that the first two years are the weak point. SimpliNow Legacy and Guaranteed Issue Whole Life generally provide a limited first-two-year death benefit equal to 110% of premiums paid absent applicable exceptions [22]. One independent review describes the same structure as a two-year waiting period with full face amount afterward [31].

On financial strength, platforms cited A-level ratings for American General Life Insurance Company: A.M. Best A, S&P A+, Moody's A2, and Fitch A+ as of April 8, 2026 [32]. A.M. Best affirmed the A (Excellent) rating in January 2026 [34] and then placed the ratings under review with developing implications in March 2026 [35].

Living benefits were also broadly reported: accelerated death-benefit riders for terminal illness and nursing-home confinement at no additional charge, with an accidental-death rider potentially available for extra cost [37].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Why do AI platforms disagree about whether Corebridge Financial is a good final expense choice for a 60-year-old nonsmoker?
  • Is Corebridge Financial's final expense pricing for $20,000 of coverage at age 60–69 verified anywhere publicly?

Fit ratings split across the panel: three platforms rated Corebridge a good fit, two rated it uncertain, and one rated it mixed (openai, anthropic, grok versus deepseek, kimi versus perplexity). That spread is the single most important caveat in this review.

The deepest disagreement is about evidence, not product design. Kimi reported that Corebridge's recommended products were not found in any retrieved 2026 independent final expense review source and could not verify pricing, underwriting, or market positioning [40]. Deepseek reached a similar conclusion, reporting no direct references to Corebridge final expense products, pricing, or underwriting in its supplied results [42]. This is missing research, not evidence of poor quality — but it does remove a layer of comparison confidence that competitors with published rates provide.

Pricing is unverified across the board. No public source established a current premium for a nonsmoking applicant aged 60–69 seeking $20,000 [43]. One platform reported a $36 annual policy fee for the level-benefit version and a $24 annual policy fee on a Guaranteed Issue rate sheet [46]; another reported a $12 annual fee for the graded version [48]. These figures conflict and require confirmation.

The first-two-year payout language also conflicts. Most sources say 110% of premiums paid; one Corebridge Direct page describes natural-death benefits in the first two years as 110%–120% of premiums paid [47]. The safer verified statement is that a graded benefit applies and the full face amount is not paid immediately for natural death.

Two further uncertainties stand out. First, one independent review reports that SimpliNow often declines healthy applicants for vague reasons, creating approval unpredictability despite average-to-good health [44]. Second, the A.M. Best under-review status follows the announced Equitable Holdings merger, with a definitive agreement announced March 26, 2026 and closing expected by year-end 2026 [49]. S&P reportedly placed Corebridge on CreditWatch Negative while Fitch showed a positive outlook — conflicting signals on the ratings outlook [52].

State availability is also unsettled. Products are described as available in 49 states and not in New York [54], and one marketing source described SimpliNow Legacy as pending approval in California without confirming current 2026 status [55].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does Corebridge Financial's SimpliNow Legacy offer a 60-year-old nonsmoker who needs $20,000 of permanent coverage?
  • Does Corebridge Financial's final expense policy include living benefits and a limited-pay option for buyers in their 60s?

The features that matter most for this buyer are speed, permanence, and the level-versus-graded choice. SimpliNow Legacy is simplified-issue whole life with instant underwriting, no tele-interview, Level and graded outcomes, included accelerated-benefit riders, and a possible accidental-death rider [56]. No medical exam is required [57].

Permanence is structural. Coverage is described as remaining in force to age 100 if premiums are paid [60], and the limited-pay design allows clients to stop paying at a maximum payment age while coverage continues to age 100 [61]. Agent materials show payment ages extending as high as age 95 for some Level offers [56].

Living benefits are included on the level death benefit option: accelerated death-benefit riders for terminal illness and nursing-home confinement at no additional cost [62]. Policy loans are permitted with no minimum loan amount [63].

The graded-versus-level distinction is the decisive feature. SimpliNow Legacy standard offers a graded death benefit paying 110% of premiums in the first two years [64], while SimpliNow Legacy Max provides a guaranteed level death benefit with full benefit starting in the first year [66]. For a buyer who wants the full $20,000 available immediately, the level design is the one that matters.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Corebridge Financial cost per month for $20,000 of final expense coverage for a 60-year-old nonsmoker?
  • What fees and contract terms apply to Corebridge Financial's SimpliNow Legacy and Guaranteed Issue Whole Life policies?

No verified premium exists publicly for this buyer profile, so cost cannot be confirmed from the supplied evidence. Pricing confidence is low across every platform that assessed it (openai, anthropic, deepseek, kimi, perplexity).

What is documented: Guaranteed Issue Whole Life premiums start at $22 per month for $5,000 of coverage and vary by issue age, gender, and coverage amount, with premiums described as fixed and not increasing [68]. Premiums depend on age, sex, tobacco status, state, face amount, payment schedule, underwriting class, and benefit design [69].

Fee reporting conflicts. One source notes a $36 annual policy fee for the level-benefit version [70]; another notes a $24 annual policy fee on a Guaranteed Issue rate sheet [71]; a third reports a $12 annual fee for the graded version [72]. Rider charges, if any, must be confirmed in the application and policy illustration [73].

Contract terms include a free-look period reported as 10 days for level and 30 days for graded, a 31-day grace period (60 days in California), and a suicide limitation returning premiums less loans in the first two years [72]. Coverage can lapse if required premiums are not paid, subject to grace-period and nonforfeiture provisions [74]. No exchanges or conversions are permitted after issue [75].

Accelerated benefit processing may carry charges: one source reports a potential $100 processing charge for nursing-home confinement acceleration and a potential $100 administrative fee for terminal-illness acceleration, with outstanding loan amounts reducing available benefits [76].

Best Suited For

Questions This Section Answers

  • Who is Corebridge Financial's SimpliNow Legacy best suited for among buyers in their 60s seeking permanent final expense coverage?
  • Is Corebridge Financial worth considering for a 60-year-old who wants fast underwriting and no medical exam?

Corebridge fits buyers who want permanent coverage, a fast no-exam process, and an established issuing insurer — and who will verify the quote before committing. The best-suited profile is a nonsmoking applicant aged 60–69 with average-to-good health who may qualify for the full Level Benefit [77].

It also suits applicants who value an established carrier with multi-agency ratings and possible accelerated-benefit riders [79], and those who want a limited-pay structure that stops premiums at a maximum payment age while coverage continues [81].

Buyers who prioritize process simplicity over lowest price are the strongest match. Instant underwriting, no medical exam, and no tele-interview remove the friction that slows traditional underwriting [82].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Corebridge Financial for final expense insurance in their 60s?
  • Is Corebridge Financial a bad choice for a healthy 60-year-old who wants the lowest possible premium?

Corebridge is probably not the best choice for healthy buyers whose primary objective is the lowest premium. Platforms flagged that applicants healthy enough to obtain competitively underwritten whole-life coverage elsewhere may get substantially better rates [84].

It is also a weaker fit for buyers who need the full death benefit immediately but qualify only for a graded or guaranteed-issue option [86]. The first-two-year limitation applies to both SimpliNow Legacy standard and Guaranteed Issue Whole Life [88].

Other poor fits: buyers unwilling to compare state-specific premiums and policy forms through an independent agent [84]; New York residents, since products are described as unavailable there [90]; buyers with complex health histories or a prior SimpliNow decline [91]; and buyers who need coverage above roughly $25,000–$35,000 [92].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Corebridge Financial for a 60-year-old who wants published rates before buying?
  • When should a buyer in their 60s choose a different carrier instead of Corebridge Financial for $20,000 of final expense coverage?

Another carrier may be better whenever price certainty or underwriting predictability matters more than Corebridge's specific product design. Platforms named several alternatives with documented pricing or underwriting characteristics.

Mutual of Omaha is cited for Level Benefit rates described as among the lowest in the market, with coverage from $2,000 to $40,000 for ages 45–85, though its underwriting is flagged as unpredictable with clean cases sometimes bumped to graded tiers [94]. Transamerica publishes sample premiums — roughly $40.77 per month for a 65-year-old female and about $54 per month for a 65-year-old male at $10,000 of coverage — and offers immediate and graded versions with a two-year waiting period and no medical exam [97]. AARP's guaranteed acceptance whole life (ages 50–85) and Gerber Life are named as established no-health-question alternatives [99].

For buyers who want maximum face-amount flexibility, Transamerica's FE Express Solution is described as offering up to $100,000 simplified issue with 10-minute decisions [101]. For buyers who want more dependable instant answers, Aetna/Accendo is noted for predictable outcomes even if rates run slightly higher [96].

A medically underwritten whole-life policy may beat all of these when the applicant's health is good enough to produce a substantially better rate [102].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Corebridge Financial before signing a final expense policy in their 60s?
  • Which Corebridge Financial product version is actually being quoted — Level, graded, or Guaranteed Issue?

Confirm the product version first: SimpliNow Legacy Level Benefit, SimpliNow Legacy Max, graded benefit, or Guaranteed Issue Whole Life [104]. Then confirm who the legal issuing insurer is in your state [106].

Request the exact monthly and annual premium for $20,000 at your age, sex, nonsmoking status, and state, and ask whether the quoted figure includes the annual policy fee [107]. Ask whether the policy pays the full $20,000 from day one or whether the 110%-of-premiums limitation applies for two years [104].

Ask what health answers would cause a Level, graded, or declined decision, and request data on approval rates for average-health applicants in your age group [110]. Confirm the maximum payment age and whether premiums can be stopped earlier without reducing coverage or creating lapse risk [111].

Request written details on the terminal-illness and nursing-home accelerated-benefit riders, including triggers, percentages, and any administrative charges [112]. Ask about the accidental-death rider cost and benefit amount [113]. Confirm grace-period, lapse, reinstatement, surrender, loan, and nonforfeiture provisions, plus the free-look period and state-specific cancellation rights [114].

Finally, ask how the Equitable Holdings merger, expected to close by year-end 2026, may affect policy terms, premiums, or claims handling [115], and compare the quote against at least two other carriers offering equivalent permanent $20,000 coverage [107].

Final AI Consensus Verdict

Corebridge Financial is a good, but not clearly lowest-cost, fit for a nonsmoking buyer aged 60–69 seeking about $20,000 of permanent final expense coverage. SimpliNow Legacy Level Benefit is the preferred Corebridge option when the applicant qualifies and the quoted premium is competitive; Guaranteed Issue Whole Life should be treated as a fallback rather than the default.

The consensus is not unanimous. Three platforms rated the fit good, two rated it uncertain, and one rated it mixed. The uncertainty traces to a single gap: no public source verified an actual premium for this buyer profile, and two platforms found no usable independent product documentation at all. That is missing evidence, not evidence of poor quality — but it means the price-competitiveness question stays open until a quote is in hand.

The strongest verified case for Corebridge is process and structure: instant underwriting, no medical exam, permanent whole life coverage, level premiums, and a Level Benefit design that pays the full amount from day one when issued on that basis. The strongest verified case against it is the first-two-year limitation on the graded and guaranteed-issue versions, the A.M. Best under-review status tied to the pending merger, and reported underwriting unpredictability for healthy applicants.

Buyers who want a fast, no-exam, permanent policy from an established carrier and who will benchmark the quote against Mutual of Omaha and Transamerica should treat Corebridge as a credible candidate. Buyers whose first priority is the lowest verified premium, or who need the full death benefit immediately without qualification risk, should shop more broadly before deciding. For the wider field of carriers evaluated for this age group, see the Final Expense Insurance for People in Their 60s consensus index.

How This Review Was Produced

This review evaluates Corebridge Financial only for the use case of Final Expense Insurance for People in Their 60s, defined as a nonsmoking consumer aged 60–69 with average-to-good health seeking approximately $20,000 of permanent final expense coverage with reasonable premiums, straightforward underwriting, a financially established carrier, and coverage intended to remain in force for life if required premiums are paid.

Seven platforms were configured for the study. Two named Corebridge during the ranking stage, and six returned a usable fit assessment. Findings were drawn from platform-reported research dated 2026-09-21, including company-owned pages, independent reviews, government filings, and journalism. Fit ratings were recorded per platform and are reported as a distribution rather than a single score.

Citations are platform-reported evidence and were not independently verified by the writer stage. Supplied URLs were collected from platform responses and were not independently validated. Where a platform supplied no citation for a factual claim, the claim is labeled platform-reported or unverified.

Methodology Limitations

Several limitations constrain how far these findings can be pushed.

First, only two of seven platforms named Corebridge during ranking discovery, so the ranking-stage signal is thin. The fit findings rest on six usable assessments, which is broader but still not unanimous.

Second, no public source verified a premium for the target buyer profile. Pricing confidence is low across every platform, and the fee figures that were reported conflict ($36, $24, and $12 annual policy fees appear in different sources).

Third, product naming is inconsistent across sources, including SimpliNow Legacy, SimpliNow Legacy Max, and Guaranteed Issue Whole Life. Public agent materials differ by revision, so the exact product version quoted must be confirmed.

Fourth, the A.M. Best rating for American General Life Insurance Company was under review with developing implications as of March 2026, following the announced Equitable Holdings merger. Rating outlook signals conflict across agencies.

Fifth, state availability, face-amount maximums, payment ages, rider packages, and first-two-year exceptions were not verified for every state. Products are described as unavailable in New York, and California status was described as pending approval in at least one marketing source without 2026 confirmation.

Sixth, one platform (deepseek) reported no direct references to Corebridge final expense products, pricing, or underwriting in its supplied results, and another (kimi) could not verify the recommended products in retrieved 2026 independent review sources. Missing research is not disagreement, and it is not evidence of poor quality — but it does limit comparison confidence.

Seventh, the supplied URLs were collected from platform responses and were not independently validated by the writer stage. Platform-reported dates are provenance metadata and do not independently prove freshness.

Sources

Company-Owned Sources

  • Final Expense Life Insurance for Seniors | Corebridge Direct: https://www.corebridgedirect.com/final-expense-insurance
  • Corebridge Financial Home: https://www.corebridgefinancial.com/home
  • Additional AI research evidence115 records
    1. AI research evidence record anthropic:1-1
    2. AI research evidence record kimi:consumeradviser-transamerica-1
    3. AI research evidence record openai:c1
    4. AI research evidence record anthropic:10-1
    5. AI research evidence record grok:web:0
    6. AI research evidence record perplexity:c1
    7. AI research evidence record openai:c4
    8. AI research evidence record anthropic:20-2
    9. AI research evidence record openai:c1
    10. AI research evidence record openai:c2
    11. AI research evidence record anthropic:2-4
    12. AI research evidence record anthropic:2-5
    13. AI research evidence record anthropic:5-6
    14. AI research evidence record anthropic:29-1
    15. AI research evidence record perplexity:c12
    16. AI research evidence record openai:c3
    17. AI research evidence record anthropic:10-1
    18. AI research evidence record perplexity:c1
    19. AI research evidence record grok:web:5
    20. AI research evidence record anthropic:1-4
    21. AI research evidence record anthropic:6-10
    22. AI research evidence record openai:c1
    23. AI research evidence record anthropic:31-1
    24. AI research evidence record perplexity:c1
    25. AI research evidence record anthropic:10-10
    26. AI research evidence record anthropic:18-1
    27. AI research evidence record grok:web:5
    28. AI research evidence record anthropic:2-10
    29. AI research evidence record anthropic:10-7
    30. AI research evidence record perplexity:c10
    31. AI research evidence record perplexity:c4
    32. AI research evidence record openai:c4
    33. AI research evidence record anthropic:20-2
    34. AI research evidence record anthropic:22-1
    35. AI research evidence record anthropic:24-2
    36. AI research evidence record openai:c5
    37. AI research evidence record openai:c2
    38. AI research evidence record anthropic:35-1
    39. AI research evidence record perplexity:c13
    40. AI research evidence record kimi:asurgo-general-1
    41. AI research evidence record kimi:consumeradviser-transamerica-1
    42. AI research evidence record deepseek:c1
    43. AI research evidence record openai:c3
    44. AI research evidence record anthropic:7-5
    45. AI research evidence record perplexity:c1
    46. AI research evidence record anthropic:34-2
    47. AI research evidence record perplexity:c10
    48. AI research evidence record grok:web:5
    49. AI research evidence record anthropic:24-4
    50. AI research evidence record anthropic:25-3
    51. AI research evidence record anthropic:25-4
    52. AI research evidence record anthropic:24-2
    53. AI research evidence record anthropic:20-2
    54. AI research evidence record anthropic:1-1
    55. AI research evidence record anthropic:5-6
    56. AI research evidence record openai:c2
    57. AI research evidence record anthropic:1-1
    58. AI research evidence record anthropic:10-3
    59. AI research evidence record anthropic:11-2
    60. AI research evidence record anthropic:31-1
    61. AI research evidence record anthropic:32-5
    62. AI research evidence record anthropic:35-1
    63. AI research evidence record anthropic:38-21
    64. AI research evidence record anthropic:2-9
    65. AI research evidence record anthropic:2-10
    66. AI research evidence record anthropic:2-4
    67. AI research evidence record anthropic:2-5
    68. AI research evidence record perplexity:c1
    69. AI research evidence record openai:c3
    70. AI research evidence record anthropic:34-2
    71. AI research evidence record perplexity:c10
    72. AI research evidence record grok:web:5
    73. AI research evidence record openai:c2
    74. AI research evidence record openai:c1
    75. AI research evidence record anthropic:2-9
    76. AI research evidence record anthropic:35-1
    77. AI research evidence record openai:c1
    78. AI research evidence record anthropic:2-4
    79. AI research evidence record openai:c4
    80. AI research evidence record anthropic:35-1
    81. AI research evidence record anthropic:32-5
    82. AI research evidence record openai:c2
    83. AI research evidence record anthropic:1-4
    84. AI research evidence record openai:c3
    85. AI research evidence record perplexity:c13
    86. AI research evidence record openai:c1
    87. AI research evidence record perplexity:c12
    88. AI research evidence record anthropic:2-10
    89. AI research evidence record anthropic:10-7
    90. AI research evidence record anthropic:1-1
    91. AI research evidence record anthropic:7-5
    92. AI research evidence record anthropic:5-6
    93. AI research evidence record grok:web:5
    94. AI research evidence record deepseek:c3
    95. AI research evidence record deepseek:c4
    96. AI research evidence record kimi:theburialinsurance-moo-1
    97. AI research evidence record deepseek:c2
    98. AI research evidence record deepseek:c5
    99. AI research evidence record deepseek:c7
    100. AI research evidence record kimi:asurgo-aarp-1
    101. AI research evidence record kimi:consumeradviser-transamerica-1
    102. AI research evidence record openai:c3
    103. AI research evidence record perplexity:c13
    104. AI research evidence record openai:c1
    105. AI research evidence record anthropic:2-9
    106. AI research evidence record openai:c4
    107. AI research evidence record openai:c3
    108. AI research evidence record anthropic:34-2
    109. AI research evidence record perplexity:c10
    110. AI research evidence record anthropic:7-5
    111. AI research evidence record anthropic:32-5
    112. AI research evidence record anthropic:35-1
    113. AI research evidence record openai:c2
    114. AI research evidence record grok:web:5
    115. AI research evidence record anthropic:25-4

Independent Sources

Other Sources

  • Our new SimpliNow LegacySM product is all about speed!: http://www.stephens-matthews.com/i/ag/smplinow/WhySimp.pdf
  • Additional AI research evidence115 records
    1. AI research evidence record anthropic:1-1
    2. AI research evidence record kimi:consumeradviser-transamerica-1
    3. AI research evidence record openai:c1
    4. AI research evidence record anthropic:10-1
    5. AI research evidence record grok:web:0
    6. AI research evidence record perplexity:c1
    7. AI research evidence record openai:c4
    8. AI research evidence record anthropic:20-2
    9. AI research evidence record openai:c1
    10. AI research evidence record openai:c2
    11. AI research evidence record anthropic:2-4
    12. AI research evidence record anthropic:2-5
    13. AI research evidence record anthropic:5-6
    14. AI research evidence record anthropic:29-1
    15. AI research evidence record perplexity:c12
    16. AI research evidence record openai:c3
    17. AI research evidence record anthropic:10-1
    18. AI research evidence record perplexity:c1
    19. AI research evidence record grok:web:5
    20. AI research evidence record anthropic:1-4
    21. AI research evidence record anthropic:6-10
    22. AI research evidence record openai:c1
    23. AI research evidence record anthropic:31-1
    24. AI research evidence record perplexity:c1
    25. AI research evidence record anthropic:10-10
    26. AI research evidence record anthropic:18-1
    27. AI research evidence record grok:web:5
    28. AI research evidence record anthropic:2-10
    29. AI research evidence record anthropic:10-7
    30. AI research evidence record perplexity:c10
    31. AI research evidence record perplexity:c4
    32. AI research evidence record openai:c4
    33. AI research evidence record anthropic:20-2
    34. AI research evidence record anthropic:22-1
    35. AI research evidence record anthropic:24-2
    36. AI research evidence record openai:c5
    37. AI research evidence record openai:c2
    38. AI research evidence record anthropic:35-1
    39. AI research evidence record perplexity:c13
    40. AI research evidence record kimi:asurgo-general-1
    41. AI research evidence record kimi:consumeradviser-transamerica-1
    42. AI research evidence record deepseek:c1
    43. AI research evidence record openai:c3
    44. AI research evidence record anthropic:7-5
    45. AI research evidence record perplexity:c1
    46. AI research evidence record anthropic:34-2
    47. AI research evidence record perplexity:c10
    48. AI research evidence record grok:web:5
    49. AI research evidence record anthropic:24-4
    50. AI research evidence record anthropic:25-3
    51. AI research evidence record anthropic:25-4
    52. AI research evidence record anthropic:24-2
    53. AI research evidence record anthropic:20-2
    54. AI research evidence record anthropic:1-1
    55. AI research evidence record anthropic:5-6
    56. AI research evidence record openai:c2
    57. AI research evidence record anthropic:1-1
    58. AI research evidence record anthropic:10-3
    59. AI research evidence record anthropic:11-2
    60. AI research evidence record anthropic:31-1
    61. AI research evidence record anthropic:32-5
    62. AI research evidence record anthropic:35-1
    63. AI research evidence record anthropic:38-21
    64. AI research evidence record anthropic:2-9
    65. AI research evidence record anthropic:2-10
    66. AI research evidence record anthropic:2-4
    67. AI research evidence record anthropic:2-5
    68. AI research evidence record perplexity:c1
    69. AI research evidence record openai:c3
    70. AI research evidence record anthropic:34-2
    71. AI research evidence record perplexity:c10
    72. AI research evidence record grok:web:5
    73. AI research evidence record openai:c2
    74. AI research evidence record openai:c1
    75. AI research evidence record anthropic:2-9
    76. AI research evidence record anthropic:35-1
    77. AI research evidence record openai:c1
    78. AI research evidence record anthropic:2-4
    79. AI research evidence record openai:c4
    80. AI research evidence record anthropic:35-1
    81. AI research evidence record anthropic:32-5
    82. AI research evidence record openai:c2
    83. AI research evidence record anthropic:1-4
    84. AI research evidence record openai:c3
    85. AI research evidence record perplexity:c13
    86. AI research evidence record openai:c1
    87. AI research evidence record perplexity:c12
    88. AI research evidence record anthropic:2-10
    89. AI research evidence record anthropic:10-7
    90. AI research evidence record anthropic:1-1
    91. AI research evidence record anthropic:7-5
    92. AI research evidence record anthropic:5-6
    93. AI research evidence record grok:web:5
    94. AI research evidence record deepseek:c3
    95. AI research evidence record deepseek:c4
    96. AI research evidence record kimi:theburialinsurance-moo-1
    97. AI research evidence record deepseek:c2
    98. AI research evidence record deepseek:c5
    99. AI research evidence record deepseek:c7
    100. AI research evidence record kimi:asurgo-aarp-1
    101. AI research evidence record kimi:consumeradviser-transamerica-1
    102. AI research evidence record openai:c3
    103. AI research evidence record perplexity:c13
    104. AI research evidence record openai:c1
    105. AI research evidence record anthropic:2-9
    106. AI research evidence record openai:c4
    107. AI research evidence record openai:c3
    108. AI research evidence record anthropic:34-2
    109. AI research evidence record perplexity:c10
    110. AI research evidence record anthropic:7-5
    111. AI research evidence record anthropic:32-5
    112. AI research evidence record anthropic:35-1
    113. AI research evidence record openai:c2
    114. AI research evidence record grok:web:5
    115. AI research evidence record anthropic:25-4

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 21, 2026
Platforms analyzed
7
Source records
37
Ranking mentions
2 of 7
Platform share
29%
Final consensus rank
#9

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

22 independent · 8 company-owned · 7 unclear

Evidence support

27 direct · 10 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

ee782f36fe337f0dfbc70a01d072538a267c67fc48ba5b3ef6fb9bc61155cb75